Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Journal for Immunotherapy of Cancer|June 16, 2022
Detection of microsatellite instability-high (MSI-H) by liquid biopsy predicts robust and durable response to immunotherapy in patients with pancreatic cancerSakti Chakrabarti, Leslie Bucheit, Jason Scott Starr, et al.
The Oncologist|July 9, 2024
Atezolizumab plus bevacizumab as first-line systemic therapy for hepatocellular carcinoma: a multi-institutional cohort studyMichael H Storandt, Tyler J Zemla, Kanchi Patell, et al.
Journal of Gastrointestinal Oncology|April 30, 2019
Local excision for patients with stage I anal canal squamous cell carcinoma can be curativeSakti Chakrabarti, Zhaohui Jin, Brandon M Huffman, et al.
Cancers|June 27, 2024
Outcome of Patients with Locally Advanced Rectal Cancer Pursuing Non-Surgical Strategy in National Cancer DatabaseHanna Kakish, Fasih A Ahmed, Lee M Ocuin, et al.
Journal of Gastrointestinal Oncology|May 18, 2023
The predictive impact of dual somatostatin receptor/fluorodeoxyglucose (FDG) positron emission tomography (PET) in metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs): review of literature and a single institution experienceAmr Mohamed, Sylvia L Asa, Zhenghong Lee, et al.
The Journal of Surgical Research|December 23, 2023
Surgical Resection Alone is Associated With Higher Long-Term Survival Than Multiagent Chemotherapy Alone for Patients With Localized Biliary Tract CancersMohamedraed Elshami, John B Ammori, Jeffrey M Hardacre, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 31, 2023
Impact of perioperative chemotherapy on survival in patients with cholangiocarcinoma undergoing curative resectionHind Hassan, Sakti Chakrabarti, Tyler Zemla, et al.
JCO Precision Oncology|August 25, 2023
Efficacy of Immune Checkpoint Inhibition and Cytotoxic Chemotherapy in Mismatch Repair-Deficient and Microsatellite Instability-High Pancreatic Cancer: Mayo Clinic ExperienceTucker Coston, Aakash Desai, Hani Babiker, et al.
Journal of Gastrointestinal Oncology|June 12, 2019
Clinicopathological features and outcomes of fibrolamellar hepatocellular carcinomaSakti Chakrabarti, Sri Harsha Tella, Anuhya Kommalapati, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 9, 2023
Disparities in guideline-compliant care for patients with pancreatic ductal adenocarcinoma at minority-versus non-minority-serving hospitalsMohamedraed Elshami, Richard S Hoehn, John B Ammori, et al.
Pageof 6